Log in
ASX:SRX

Sirtex Medical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.89%
BetaN/A
Sirtex Medical Limited, a life-sciences company, develops and delivers oncology treatments using novel small particle technology in the Asia-Pacific, Europe, the Middle East, Africa, and North and South America. The company's principal product is the SIR-Spheres Y-90 resin microspheres, a targeted radioactive treatment for primary and secondary metastatic liver cancer. Sirtex Medical Limited is headquartered in North Sydney, Australia.
Read More
Sirtex Medical logo

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.44 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolASX:SRX
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.sirtex.com
Phone+61-2-99648400

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive SRX News and Ratings via Email

Sign-up to receive the latest news and ratings for SRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sirtex Medical (ASX:SRX) Frequently Asked Questions

How were Sirtex Medical's earnings last quarter?

Sirtex Medical Limited (ASX:SRX) issued its quarterly earnings results on Wednesday, August, 29th. The medical device company reported $0.74 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.97 by $0.23.
View Sirtex Medical's earnings history.

Who are some of Sirtex Medical's key competitors?

Some companies that are related to Sirtex Medical include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Acrux (ACR), Actinogen Medical (ACW), Adalta (1AD), Admedus (AHZ), Almirall (LBTSF), Amarantus Bioscience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR), Antibe Therapeutics (VBIZF), Aortech International (RUA), Apotheca Biosciences (CBDC) and Arno Therapeutics (ARNI).
View all competitors.

What other stocks do shareholders of Sirtex Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sirtex Medical investors own include Capricorn Metals (CMM), Woodside Petroleum (WPL), Bristol-Myers Squibb (BMY), REA Group (REA), WOODSIDE PET LT/ADR (WOPEY), Cardinal Health (CAH), BTG (BTG), Boston Scientific (BSX), Blackmores (BKL) and BHP Group (BHP).

Who are Sirtex Medical's key executives?

Sirtex Medical's management team includes the following people:
  • Mr. Andrew McLean, CEO, MD Exec. Director
  • Mr. Darren Smith M.B.A., B.Bus., FCPA, CFO & Company Sec. (Age 53)
  • Mr. Anthony Dixon, Exec. VP of Sales & Marketing - EMEA
  • Mr. G. Spindler, Global Head of Operations
  • Dr. Thomas Duthy, Global Head of Investor Relations & Corp. Devel.

What is Sirtex Medical's stock symbol?

Sirtex Medical trades on the ASX under the ticker symbol "SRX."

What is Sirtex Medical's official website?

The official website for Sirtex Medical is www.sirtex.com.

How can I contact Sirtex Medical?

Sirtex Medical's mailing address is L 33 101 Miller St, NORTH SYDNEY, NSW 2060, Australia. The medical device company can be reached via phone at +61-2-99648400.

This page was last updated on 9/19/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.